share_log
Reuters ·  Jan 9 20:04
Arkuda Therapeutics: J&J Exercised Option to Buy Co's Portfolio of Lysosomal Function Enhancers for Upfront Payment & Extra Milestone Payments
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment